Advisory Services Network buys $1,120,162 stake in Laboratory Corp. of America Holdings (LH)

Laboratory Corp. of America Holdings (LH) : Advisory Services Network scooped up 1,734 additional shares in Laboratory Corp. of America Holdings during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 9,199 shares of Laboratory Corp. of America Holdings which is valued at $1,120,162.Laboratory Corp. of America Holdings makes up approximately 0.30% of Advisory Services Network’s portfolio.

Laboratory Corp. of America Holdings opened for trading at $127 and hit $127.19 on the upside on Wednesday, eventually ending the session at $127, with a gain of 0.21% or 0.26 points. The heightened volatility saw the trading volume jump to 11,96,293 shares. Company has a market cap of $12,916 M.

Other Hedge Funds, Including , Cardinal Capital Management boosted its stake in LH in the latest quarter, The investment management firm added 506 additional shares and now holds a total of 29,592 shares of Laboratory Corp. of America Holdings which is valued at $3,603,418. Laboratory Corp. of America Holdings makes up approx 1.48% of Cardinal Capital Management’s portfolio.Watch Point Trust Co reduced its stake in LH by selling 155 shares or 2.87% in the most recent quarter. The Hedge Fund company now holds 5,245 shares of LH which is valued at $638,684. Laboratory Corp. of America Holdings makes up approx 0.56% of Watch Point Trust Co’s portfolio.Winslow Evans Crocker boosted its stake in LH in the latest quarter, The investment management firm added 30 additional shares and now holds a total of 9,278 shares of Laboratory Corp. of America Holdings which is valued at $1,129,782. Laboratory Corp. of America Holdings makes up approx 0.33% of Winslow Evans Crocker’s portfolio.Franklin Street Advisors Inc Nc boosted its stake in LH in the latest quarter, The investment management firm added 9,911 additional shares and now holds a total of 36,696 shares of Laboratory Corp. of America Holdings which is valued at $4,387,374. Laboratory Corp. of America Holdings makes up approx 0.86% of Franklin Street Advisors Inc Nc’s portfolio.

On the company’s financial health, Laboratory Corp. of America Holdings reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 25, 2016. Analyst had a consensus of $1.96. The company had revenue of $2295.20 million for the quarter, compared to analysts expectations of $2184.25 million. The company’s revenue was up 29.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.73 EPS.

Many Wall Street Analysts have commented on Laboratory Corp. of America Holdings. Company shares were Reiterated by Mizuho on Apr 26, 2016 to “Neutral”, Firm has raised the Price Target to $ 132 from a previous price target of $119 .Company shares were Reiterated by Canaccord Genuity on Apr 26, 2016 to “Buy”, Firm has raised the Price Target to $ 140 from a previous price target of $135 .Company shares were Reiterated by Barclays on Apr 26, 2016 to “Overweight”, Firm has raised the Price Target to $ 155 from a previous price target of $152 .

Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories the Company offers a range of clinical laboratory tests that are used by the medical profession in core testing patient diagnosis and in the monitoring and treatment of disease. The Company manages its operations through two segments: the Clinical diagnostics laboratory segment which includes core testing as well as genomic and esoteric testing; and the Other segment which consists of the Company’s non-United States clinical diagnostic laboratory operations in Ontario Canada. It also provides specialty testing services in the areas of allergy clinical trials diagnostic genetics women’s health cardiovascular disease identity forensics infectious disease endocrinology oncology coagulation occupational testing and pain management.

Leave a Reply

Laboratory Corp. of America Holdings - Is it time to Sell?

Top Brokerage Firms are advising their investors on Laboratory Corp. of America Holdings. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.